Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lurtotecan SCHEMBL13992 | 1.00 | TOP1 (1.00) | TOP1SLC2A1 | |
| Lurtotecan SCHEMBL29774186 | 1.00 | TOP1 (1.00) | TOP1SLC2A1 | |
| Lurtotecan SCHEMBL1649335 | 0.99 | TOP1 (0.98) | TOP1SLC2A1 | |
| Lurtotecan SCHEMBL29379042 | 0.99 | TOP1 (0.98) | TOP1SLC2A1 | |
| Lurtotecan SCHEMBL1649336 | 0.98 | TOP1 (0.97) | TOP1SLC2A1 | |
| SCHEMBL31312371 | 0.95 | TOP1 (1.00) | TOP1SLC2A1 | |
| SCHEMBL21410041 | 0.95 | TOP1 (1.00) | TOP1SLC2A1 | |
| SCHEMBL21450469 | 0.95 | TOP1 (1.00) | TOP1SLC2A1 | |
| SCHEMBL15150090 | 0.93 | TOP1 (0.87) | TOP1SLC2A1 | |
| SCHEMBL17057475 | 0.92 | TOP1 (0.86) | TOP1SLC2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 22729 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144882-A1 | ANTI-NECTIN-4 ANTIBODY DRUG CONJUGATE AND USE THEREOF | BIO-THERA SOLUTIONS, LTD. (CN) | 2026-05-28 | — | — | US | claimed |
| US-20260137796-A1 | PHARMACEUTICAL COMBINATIONS FOR SUBCUTANEOUS ADMINISTRATION AND USE THEREOF | SHANGHAI BAO PHARMACEUTICALS CO., LTD. (CN) | 2026-05-21 | — | — | US | claimed |
| EP-4743122-A1 | THERAPEUTIC SEALANTS BASED UPON DRUG CONJUGATES | The Johns Hopkins University (US) | 2026-05-20 | — | — | EP | claimed |
| EP-4739310-A1 | ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 (ENPP1) INHIBITOR COMBINATIONS AND USES THEREOF | Insilico Medicine IP Limited (HK) | 2026-05-13 | — | — | EP | claimed |
| EP-4740956-A1 | PHARMACEUTICAL COMBINATION FOR SUBCUTANEOUS ADMINISTRATION AND USE THEREOF | Shanghai Bao Pharmaceuticals Co., Ltd. (CN) | 2026-05-13 | — | — | EP | claimed |
| US-20260116861-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-04-30 | — | — | US | claimed |
| WO-2026090139-A1 | ANTI-LY6K ANTIBODY-DRUG CONJUGATES AND METHODS OF USE | NORMUNITY, INC. (US) | 2026-04-30 | — | — | WO | claimed |
| EP-4732850-A1 | ANTIBODY-DRUG CONJUGATES AND THEIR USES | Antelope Therapeutics SAS (FR) | 2026-04-29 | — | — | EP | claimed |
| US-20260091119-A1 | ISOLATED TARGETED DELIVERY SYSTEM FOR THE TREATMENT OF GLIOMA | CELLIS AG (CH) | 2026-04-02 | — | — | US | claimed |
| EP-4687999-A1 | TROP2 CONJUGATED BIOLOGICAL MOLECULES, PHARMACEUTICAL COMPOSITIONS AND METHODS | OBI Pharma, Inc. (TW) | 2026-02-11 | — | — | EP | claimed |
| EP-1267939-A2 | POLYGLUTAMIC ACID-CAMPTOTHECIN CONJUGATES AND METHODS OF PREPARATION | CELL THERAPEUTICS, INC. (US) | 2003-01-02 | — | — | EP | claimed |
| US-20020183243-A1 | Polyglutamic acid-camptothecin conjugates and methods of preparation | CELL THERAPEUTICS, INC. | 2002-12-05 | — | — | US | claimed |
| WO-2002085459-A2 | ANTIANGIOGENIC COMBINATION THERAPY FOR THE TREATMENT OF CANCER | PHARMACIA CORPORATION (US) | 2002-10-31 | — | — | WO | claimed |
| US-20020103141-A1 | Antiangiogenic combination therapy for the treatment of cancer | PHARMACIA CORPORATION | 2002-08-01 | — | — | US | claimed |
| WO-2002053138-A2 | TREATMENT FOR INHIBITING NEOPLASTIC LESIONS USING INCENSOLE AND/OR FURANOGERMACRENS | SHANAHAN-PRENDERGAST ELISABETH (IE) | 2002-07-11 | — | — | WO | claimed |
| US-20020077290-A1 | Polyglutamic acid-camptothecin conjugates and methods of preparation | CELL THERAPEUTICS, INC. | 2002-06-20 | — | — | US | claimed |
| EP-1210354-A1 | PRODRUGS FOR LIVER SPECIFIC DRUG DELIVERY | Metabasis Therapeutics, Inc. (US) | 2002-06-05 | — | — | EP | claimed |
| US-20020016285-A1 | Polyglutamic acid-camptothecin conjugates and methods of preparation | CELL THERAPEUTICS, INC. | 2002-02-07 | — | — | US | claimed |
| WO-2001070275-A2 | POLYGLUTAMIC ACID-CAMPTOTHECIN CONJUGATES AND METHODS OF PREPARATION | CELL THERAPEUTICS, INC. (US) | 2001-09-27 | — | — | WO | claimed |
| WO-2001018013-A1 | PRODRUGS FOR LIVER SPECIFIC DRUG DELIVERY | METABASIS THERAPEUTICS, INC. (US) | 2001-03-15 | — | — | WO | claimed |